Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

MediPrint Announces Positive Results for Glaucoma Lens

MediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a 3D-printed, drug-eluting contact lens designed to treat mild to moderate glaucoma. These results, presented by Ian Ben Gaddie, OD, FAAO, at the American Academy of…

Atsena & Nippon Shinyaku Partner on ATSN-101

Atsena Therapeutics, Inc. and Nippon Shinyaku Co., Ltd. have entered an exclusive licensing agreement to advance and commercialize ATSN-101, an investigational gene therapy for Leber congenital amaurosis type 1 (LCA1), in both the United States and Japan. ATSN-101 is designed…

Oklahoma Doctor Wins $2.3M NIH for Retinopathy Research

Dr. Faizah Bhatti, a neonatologist and researcher from the University of Oklahoma, has been awarded a 5-year, $2.3 million grant from the National Institutes of Health (NIH) to investigate the role of surfactant protein A in the development of retinopathy…

Harrow Gains Medicare Part D Access for Vevye in 2025

Harrow has announced that its dry eye disease treatment, Vevye, will be added to the formularies of key Medicare Part D plan sponsors starting January 1, 2025. Major plan sponsors including Express Scripts, Cigna, Kaiser Permanente, and CVS Caremark, which…

Top 15 International Ophthalmology Congresses in 2024

As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…

What Is Ophthalmia Neonatorum? | OBN

Ophthalmia neonatorum, also known as neonatal conjunctivitis, is an inflammation of the conjunctiva (the clear membrane covering the white part of the eye) that occurs in newborns. It is a serious condition that can lead to blindness if left untreated.…

Alcon Launches PRECISION7 One-Week Contact Lens

Alcon has announced the U.S. launch of PRECISION7, a groundbreaking contact lens designed for a convenient one-week replacement cycle. Incorporating the advanced 7-day ACTIV-FLO system, these lenses offer up to 16 hours of comfort and clear vision, even on the…

Stay informed and not overwhelmed, subscribe now!